Please Wait
Applying Filters...
menu
    • menu
    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Menu

    Docosanol

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,793Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Encube's Generic Docosanol Receives Approval in the U.S.
    Encube's Generic Docosanol Receives Approval in the U.S.

    07 Oct 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212385

    FDA
    07 Oct 2022
    Share Share
    Cosette Pharma, Alembic Pharma Announce the Approval and Launch of NBE of Abreva
    Cosette Pharma, Alembic Pharma Announce the Approval and Launch of NBE of Abreva

    24 May 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220524005173/en

    BUSINESSWIRE
    24 May 2022
    Share Share
    Aleor Dermaceuticals receives final USFDA approval for cold sore drug
    Aleor Dermaceuticals receives final USFDA approval for cold sore drug

    04 May 2022

    // ET HEALTH

    https://health.economictimes.indiatimes.com/news/pharma/aleor-dermaceuticals-receives-final-usfda-approval-for-cold-sore-drug/91309474

    ET HEALTH
    04 May 2022
    Share Share
    Actavis Labs' Generic Docosanol Receives Approval in US
    Actavis Labs' Generic Docosanol Receives Approval in US

    21 Nov 2018

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208754

    FDA
    21 Nov 2018
    Share Share